Literature DB >> 10024541

Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis.

I M Nilsson1, O Hartford, T Foster, A Tarkowski.   

Abstract

Septic arthritis is a common and feared complication of staphylococcal infections. Staphylococcus aureus produces a number of potential virulence factors including certain adhesins and enterotoxins. In this study we have assessed the roles of cytolytic toxins in the development of septic arthritis by inoculating mice with S. aureus wild-type strain 8325-4 or isogenic mutants differing in the expression of alpha-, beta-, and gamma-toxin production patterns. Mice inoculated with either an alpha- or beta-toxin mutant showed degrees of inflammation, joint damage, and weight decrease similar to wild-type-inoculated mice. In contrast, mice inoculated with either double (alpha- and gamma-toxin-deficient)- or triple (alpha-, beta-, and gamma-toxin-deficient)-mutant S. aureus strains showed lower frequency and severity of arthritis, measured both clinically and histologically, than mice inoculated with the wild-type strain. We conclude that simultaneous production of alpha- and gamma-toxin is a virulence factor in S. aureus arthritis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10024541      PMCID: PMC96427          DOI: 10.1128/IAI.67.3.1045-1049.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Improved purification of leukocidin from Staphylococcus aureus and toxin distribution among hospital strains.

Authors:  V Finck-Barbançon; G Prévost; Y Piémont
Journal:  Res Microbiol       Date:  1991-01       Impact factor: 3.992

2.  Staphylococcal alpha-toxin: a study of membrane penetration and pore formation.

Authors:  S Harshman; P Boquet; E Duflot; J E Alouf; C Montecucco; E Papini
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

3.  Histopathological and serological progression of experimental Staphylococcus aureus arthritis.

Authors:  T Bremell; A Abdelnour; A Tarkowski
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

4.  Interleukin-6 attenuates agonist-mediated calcium mobilization in murine osteoblastic cells.

Authors:  J Green; S Schotland; Z Sella; C R Kleeman
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

5.  The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model.

Authors:  A Abdelnour; S Arvidson; T Bremell; C Rydén; A Tarkowski
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

Review 6.  Alpha-toxin of Staphylococcus aureus.

Authors:  S Bhakdi; J Tranum-Jensen
Journal:  Microbiol Rev       Date:  1991-12

7.  Experimental Staphylococcus aureus arthritis in mice.

Authors:  T Bremell; S Lange; A Yacoub; C Rydén; A Tarkowski
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

8.  Activation of cytosolic phospholipase A2 in permeabilized human neutrophils.

Authors:  S A Bauldry; R E Wooten; D A Bass
Journal:  Biochim Biophys Acta       Date:  1996-01-19

9.  Roles of alpha-toxin and beta-toxin in virulence of Staphylococcus aureus for the mouse mammary gland.

Authors:  A J Bramley; A H Patel; M O'Reilly; R Foster; T J Foster
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

10.  Pore-forming bacterial toxins potently induce release of nitric oxide in porcine endothelial cells.

Authors:  N Suttorp; M Fuhrmann; S Tannert-Otto; F Grimminger; S Bhadki
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  63 in total

1.  Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo.

Authors:  Francis Alonzo; Meredith A Benson; John Chen; Richard P Novick; Bo Shopsin; Victor J Torres
Journal:  Mol Microbiol       Date:  2011-12-20       Impact factor: 3.501

2.  IL-26 contributes to host defense against intracellular bacteria.

Authors:  Angeline Tilly Dang; Rosane Mb Teles; David I Weiss; Kislay Parvatiyar; Euzenir N Sarno; Maria T Ochoa; Genhong Cheng; Michel Gilliet; Barry R Bloom; Robert L Modlin
Journal:  J Clin Invest       Date:  2019-04-02       Impact factor: 14.808

Review 3.  The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

Review 4.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

Review 5.  Mouse models for infectious diseases caused by Staphylococcus aureus.

Authors:  Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  J Immunol Methods       Date:  2014-04-24       Impact factor: 2.303

6.  Defining the strain-dependent impact of the Staphylococcal accessory regulator (sarA) on the alpha-toxin phenotype of Staphylococcus aureus.

Authors:  Agnieszka K Zielinska; Karen E Beenken; Hwang-Soo Joo; Lara N Mrak; Linda M Griffin; Thanh T Luong; Chia Y Lee; Michael Otto; Lindsey N Shaw; Mark S Smeltzer
Journal:  J Bacteriol       Date:  2011-04-08       Impact factor: 3.490

7.  Staphylococcus aureus beta-toxin induces lung injury through syndecan-1.

Authors:  Atsuko Hayashida; Allison H Bartlett; Timothy J Foster; Pyong Woo Park
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

Review 8.  The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes.

Authors:  S Anwar; L R Prince; S J Foster; M K B Whyte; I Sabroe
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

9.  Colostrum hexasaccharide, a novel Staphylococcus aureus quorum-sensing inhibitor.

Authors:  A Srivastava; B N Singh; D Deepak; A K S Rawat; B R Singh
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

10.  Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells.

Authors:  Robin R Craven; Xi Gao; Irving C Allen; Denis Gris; Juliane Bubeck Wardenburg; Erin McElvania-Tekippe; Jenny P Ting; Joseph A Duncan
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.